Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VMT-a-NET by Perspective Therapeutics for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET): Likelihood of Approval
VMT-a-NET is under clinical development by Perspective Therapeutics and currently in Phase II for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET). According to...
VMT-a-NET by Perspective Therapeutics for Pheochromocytoma: Likelihood of Approval
VMT-a-NET is under clinical development by Perspective Therapeutics and currently in Phase II for Pheochromocytoma. According to GlobalData, Phase II...
VMT-a-NET by Perspective Therapeutics for Neuroendocrine Tumors: Likelihood of Approval
VMT-a-NET is under clinical development by Perspective Therapeutics and currently in Phase II for Neuroendocrine Tumors. According to GlobalData, Phase...
VMT-a-NET by Perspective Therapeutics for Medullary Thyroid Cancer: Likelihood of Approval
VMT-a-NET is under clinical development by Perspective Therapeutics and currently in Phase II for Medullary Thyroid Cancer. According to GlobalData,...